Author： Burns D.M. Ruddock M.W. Walker M.D. Allen J.M. Kennovin G.D. Hirst D.G.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.374, Iss.2, 1999-06, pp. : 213-220
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IDO+ DCs and Signalling Pathways
Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. :
Access to resources
Recommend
Non-neuronal glutamate signalling pathways
Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 3, 2000-06 ,pp. :
Targeting Signalling Pathways in Hepatocellular Carcinoma
Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. :
Agonist Replacement for Stimulant Dependence: A Review of Clinical Research
Current Pharmaceutical Design, Vol. 19, Iss. 40, 2013-12 ,pp. :